EVEREST MED.LTD DL-0001 (6HN) — Tangible Net Worth Ratio
EVEREST MED.LTD DL-0001 (6HN) has a Tangible Net Worth Ratio of 60.0% as of December 2025. This metric is calculated by deducting intangible assets (€2.12 Billion) from net assets (€5.30 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 6HN net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
EVEREST MED.LTD DL-0001 Tangible Net Worth Ratio (2021–2025)
This chart shows how EVEREST MED.LTD DL-0001's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 60.0%, reflecting net assets of €5.30 Billion with intangible assets of €2.12 Billion EUR. Also explore net asset momentum of EVEREST MED.LTD DL-0001 to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for EVEREST MED.LTD DL-0001 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for EVEREST MED.LTD DL-0001 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of EVEREST MED.LTD DL-0001.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 60.0% | €5.30 Billion | €2.12 Billion | €6.83 Billion | ▲ +16.1 pp |
| 2024 | 43.9% | €4.07 Billion | €2.29 Billion | €4.96 Billion | ▼ -4.7 pp |
| 2023 | 48.5% | €4.97 Billion | €2.56 Billion | €5.77 Billion | ▼ -8.8 pp |
| 2022 | 57.3% | €5.65 Billion | €2.41 Billion | €6.61 Billion | ▲ +5.7 pp |
| 2021 | 51.6% | €5.89 Billion | €2.85 Billion | €6.65 Billion | — |